Stuart, R. K., Cripe, L. D., Maris, M. B., Cooper, M. A., Stone, R. M., Dakhil, S. R., . . . Ravandi, F. (2015). REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia. Br J Haematol.
Citação norma ChicagoStuart, Robert K., et al. "REVEAL-1, a Phase 2 Dose Regimen Optimization Study of Vosaroxin in Older Poor-risk Patients With Previously Untreated Acute Myeloid Leukaemia." Br J Haematol 2015.
Citação norma MLAStuart, Robert K., et al. "REVEAL-1, a Phase 2 Dose Regimen Optimization Study of Vosaroxin in Older Poor-risk Patients With Previously Untreated Acute Myeloid Leukaemia." Br J Haematol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.